Company Overview and News

 
Haranga Resources to reveal material news

2017-05-30 proactiveinvestors.com.au
The halt will remain in place until the opening of trade on Thursday 1st June 2017, or earlier if an announcement is made to the market.

 
Haranga Resources tops ASX % Gainers intra-day

2017-02-16 proactiveinvestors.com.au

 
Latin Resources Ltd granted further lithium ground, drilling soon

2016-11-21 proactiveinvestors.com.au
Latin Resources Ltd (ASX:LRS) has been granted its final two tenements totalling 7,050 hectares, which expand the now 76,700 hectare Catamarca lithium project in Argentina.

 
Latin Resources Ltd appoints new exploration and development manager

2016-11-16 proactiveinvestors.com.au
Griffin will be on site in Argentina next week and will be managing the drilling program on the Catamarca project and coordinating the exploration on other Latin Resources projects.

 
Copper Investing In Mongolia

2016-09-19 seekingalpha
Mongolia's predicted economic boom hinges on the premise that the Oyu Tolgoi copper-gold mine will be a driver of the economy's growth. Mongolia's GDP in 2010 was $6.8 billion. Oyu Tolgoi is expected to produce over $3 billion per year using prices of $850/oz. for gold, $14/oz. for silver, and $2/pound for copper. The current prices for all these commodities are higher -- copper prices are more than 50% higher while gold and silver are both approximately double those prices -- thus the effect of Oyu Tolgoi on the Mongolian economy will be greater.

 
Annual Report - 30 June 2016

2016-09-12 londonstockexchange
The Directors present their report for Harvest Minerals Limited ('Harvest' or 'the Company') and its subsidiaries ('the Group') for the year ended 30 June 2016. The Annual Report has today been posted to shareholders.

 
Quarterly Activities Report

2016-04-27 asx.com.au

 
Quarterly Cashflow Report

2016-04-27 asx.com.au

 
2015 Annual Report

2016-03-31 asx.com.au

 
Appendix 4G

2016-03-31 asx.com.au

 
Expiry of Unlisted Options

2016-03-30 asx.com.au

 
Change in substantial holding

2016-03-01 asx.com.au

 
Change in substantial holding

2016-03-01 asx.com.au

Related Articles

ANTH: Anthera Pharmaceuticals Analysis and Research Report

2018-05-21 - Asif

Overview Anthera Pharmaceuticals, Inc. is a biopharmaceutical company focused on advancing the development and commercialization of innovative medicines that benefit patients with unmet medical needs. The company currently have two compounds in development, Sollpura and blisibimod. The company licensed Sollpura from Eli Lilly & Co (“Eli Lilly”) in July 2014. Sollpura is a novel non-porcine investigational Pancreatic Enzyme Replacement Therapy (“PERT”) intended for the treatment of patients with Exocrine Pancreatic Insufficiency (“EPI”), often seen in patients with cystic fibrosis and other conditions. The company licensed blisibimod from Amgen, Inc. (“Amgen”) in December 2007. Blisibimod targets B-cell activating factor, or BAFF, which has been shown to be elevated in a variety of B-cell mediated autoimmune diseases, including Immunoglobulin A nephropathy, or IgA nephropathy. Sollpura The exocrine pancreas is responsible for synthesis and secretion of digestive en...

AGEN: Agenus Inc Analysis and Research Report

2018-05-21 - Asif

Business Agenus is a clinical-stage immuno-oncology (“I-O”) company dedicated to becoming a leader in the discovery and development of innovative combination therapies and committed to bringing effective medicines to patients with cancer. The company's business is designed to drive success in I-O through speed, innovation, and effective combination therapies. Agenus has assembled fully integrated capabilities from novel target discovery, antibody generation, cell line development, and good manufacturing practice (“GMP”) manufacturing together with a comprehensive portfolio consisting of antibody-based therapeutics, adjuvants and cancer vaccine platforms. The company leverage its immune biology platforms to identify effective combination therapies for development and have developed productive partnerships to advance its innovation. The company believe the next generation of cancer treatment will build on clinically validated antibodies targeting CTLA-4 and PD-1 combined wi...

SQ: Square Analysis and Research Report

2018-05-21 - Asif

Business The company started Square in February 2009 to enable businesses (sellers) to accept card payments, an important capability that was previously inaccessible to many businesses. However, sellers also need innovative solutions to thrive, and Square has since expanded to provide additional products and services to give these businesses access to the same tools as large businesses. This approach aligns with its purpose of economic empowerment, as everything the company do should give sellers accessible, affordable tools to grow their businesses and participate in the economy. Square is a cohesive commerce ecosystem that helps its sellers start, run, and grow their businesses. The company combine sophisticated software with affordable hardware to enable sellers to turn mobile and computing devices into powerful payment and point-of-sale solutions. Square has high seller acceptance rates and fast onboarding, while maintaining low risk and fraud losses as a result of its a...